LaingBuisson News
Benedikt von Braunmühl, chief operating officer of diagnostics services at Medicover, will be departing the company after more than four years in the role. Medicover said he has decided to pursue other opportunities and that the company will begin the recruitment for a replacement COO soon. Braunmühl is currently chairman of the board of directors…
You must be a HMI Subscriber to view this content. Please log in or subscribe below.
TAGS
M&A exits in Israel were down by approximately 30% in Israel during 2020, with the average deal size falling from $143 million in 2019 to $93 million according to IVC. An increase in the number of IPOs, SPACs and the large size of late-stage funding for growth capital, are just some of the reasons for this drop. Another possible reason though, is the dependence of Israeli startups on U.S. companies, with 90% of all M&A exits being completed by U.S. companies.
So, why are most of the M&A’s with U.S. companies? Most of the foreign investment banks in Israel are American or are staffed by American bankers that rarely look at European suitors as buyers of Israeli tech companies. Those offices that are staffed by Israeli bankers are generalists and are mostly passing the work to their counterparts in New York or San Francisco. They are not taking the steps to explore European companies as potential acquirers of Israeli companies. Although American buyers typically pay higher for tech